The Chemours Company

… than 3,000 people now work at the STAR campus every day. That includes more than 300 scientists and researchers at the Chemours Research and Discovery Hub. The university’s partnership with Chemours allows students to train right alongside ind …

… st in the U.S. on a per capita basis and fifth in absolute terms. In response to the potential loss of The Chemours Company (NYSE: CC), Delaware enacted The Delaware Competes Act resulting in Chemours’ commitment to maintain its ad …

… rs to advance U.S. leadership in making the medicines of the future. The Biopharmaceutical Innovation Building joins the Chemours Discovery Hub and the Tower at STAR, a 10-story building that houses the University’s College of Health Sciences as w …

… st in the U.S. on a per capita basis and fifth in absolute terms. In response to the potential loss of The Chemours Company (NYSE: CC), Delaware enacted The Delaware Competes Act resulting in Chemours’ commitment to maintain its ad …

… rs to advance U.S. leadership in making the medicines of the future. The Biopharmaceutical Innovation Building joins the Chemours Discovery Hub and the Tower at STAR, a 10-story building that houses the University’s College of Health Sciences as w …

… st in the U.S. on a per capita basis and fifth in absolute terms. In response to the potential loss of The Chemours Company (NYSE: CC), Delaware enacted The Delaware Competes Act resulting in Chemours’ commitment to maintain its ad …

… rs to advance U.S. leadership in making the medicines of the future. The Biopharmaceutical Innovation Building joins the Chemours Discovery Hub and the Tower at STAR, a 10-story building that houses the University’s College of Health Sciences as w …

… ranking first in the U.S. on a per capita basis and fifth in absolute terms. In response to the poten tial loss of The Chemours Company (NYSE: CC), Delaware enacted The Delaware Competes Act resultin g in Chemours’ commitment to maintain its a …

… rs to advance U.S. leadership in making the medicines of the future. The Biopharmaceutical Innovation Building joins the Chemours Discovery Hub and the Tower at STAR, a 10-story building that houses the University’s College of Health Sciences as …

… ranking first in the U.S. on a per capita basis and fifth in absolute terms. In response to the poten tial loss of The Chemours Company (NYSE: CC), Delaware enacted The Delaware Competes Act resultin g in Chemours’ commitment to maintain its a …

… rs to advance U.S. leadership in making the medicines of the future. The Biopharmaceutical Innovation Building joins the Chemours Discovery Hub and the Tower at STAR, a 10-story building that houses the University’s College of Health Sciences as …

… ranking first in the U.S. on a per capita basis and fifth in absolute terms. In response to the poten tial loss of The Chemours Company (NYSE: CC), Delaware enacted The Delaware Competes Act resultin g in Chemours’ commitment to maintain its a …

… rs to advance U.S. leadership in making the medicines of the future. The Biopharmaceutical Innovation Building joins the Chemours Discovery Hub and the Tower at STAR, a 10-story building that houses the University’s College of Health Sciences as …